Abstract | OBJECTIVE: The best management of asymptomatic moyamoya disease (MMD) remains controversial. In this study, the authors aimed to explore an experience for treatment modality for asymptomatic MMD. METHODS: The authors retrospectively reviewed a total of 23 patients (age range 30-58 years) with asymptomatic MMD during the past 5 years at their institutions. The patients were divided into 2 groups: The surgical group included 11 patients, and the conservative group included 12 patients. The demographic, radiologic, and clinical findings of the patients were evaluated. At follow-up over 13-65 months, the future clinical and radiologic progression events were evaluated. RESULTS: CONCLUSIONS: Surgical treatment may be an alternative choice for patients with asymptomatic MMD. However, the best strategy for asymptomatic MMD in order to reduce future cerebrovascular risks still needs to be further explored.
|
Authors | Hanhai Zeng, Yinghan Guo, Yin Li, Xiaobo Yu, Feng Yan, Xiaoxiao Tan, Hangzhe Xu, Yucong Peng, Jianfeng Zhuang, Hang Zhou, Xiongjie Fu, Lin Wang, Gao Chen |
Journal | World neurosurgery
(World Neurosurg)
Vol. 146
Pg. e955-e960
(02 2021)
ISSN: 1878-8769 [Electronic] United States |
PMID | 33217589
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Topics |
- Adult
- Angiography, Digital Subtraction
- Asymptomatic Diseases
- Cerebral Angiography
- Cerebral Revascularization
(methods)
- Conservative Treatment
- Disease Progression
- Female
- Humans
- Ischemic Attack, Transient
(epidemiology, etiology)
- Magnetic Resonance Angiography
- Male
- Middle Aged
- Moyamoya Disease
(complications, therapy)
- Progression-Free Survival
- Retrospective Studies
- Stroke
(epidemiology, etiology)
|